Novo Nordisk’s Wegovy-Fueled Gains Fading as Analyst Doubts Grow
The obesity-drug hype that fueled huge gains in Novo Nordisk A/S looks to be running out of steam.Most Read from ...
What to Eat (& Not to Eat) When Taking Wegovy for Weight Loss
Wegovy is a once-weekly injection approved by the U.S. Food and Drug Administration (FDA) to treat obesity in people 12 and ...
Women Are Losing More Weight on Ozempic—Scientists Are Finally Figuring Out Why
A new study published in JAMA Network Open contends that women may lose more weight on semaglutides like Ozempic than men.
What are Ozempic and Wegovy, the weight loss drugs everyone is talking about?
Although not available in India in injectible form, new weight loss drugs Ozempic and Wegovy are all the rage. Lounge speaks ...
Let’s talk about semaglutide — is it safe, and who should consider it?
Semaglutide belongs to a class of prescription medications that mimic a hormone your body naturally produces after you eat. This hormone helps your pancreas make insulin, which lowers your blood sugar ...
Novo Nordisk Just Committed More Than $1.1 Billion to Make the Next Ozempic, but Is the Stock a Buy?
In mid-September, Novo Nordisk inked a pair of deals worth a total of more than $1.1 billion in research and development (R&D ...
What is 'Ozempic face'? How we refer to weight-loss side effects matters.
The term "Ozempic face" is not a medical term, but some use it to describe this type of appearance after weight loss. Here what's fact and fiction.
CBS News15h
New weight loss drugs spark eating disorder concerns in teens
BOSTON - There is concern over the newest weight loss drugs sparking eating disorders in teens. Newer GLP-1 weight loss drugs ...
Everyone’s on Ozempic. So why will no one talk about it?
That Ozempic (or Wegovy, the name by which the weight-loss version of the drug semaglutide is marketed) should have proliferated in an industry that has always venerated thinness will hardly come as a ...
GlobalData on MSN22h
EADV 2024: Wegovy shows promise in treating common, chronic skin condition
Novo Nordisk’s Wegovy has shown promising benefits in treating a common, chronic skin condition hidradenitis suppurative (HS) ...
Weight loss injections boom
An emerging market for compounded weight loss injections that mimic brand-name drugs such as Ozempic, Wegovy, Mounjaro and ...
Can semaglutide help reduce opioid overdoses? What new study suggests
Semaglutide – a key ingredient in Ozempic and Wegovy – was associated with a lower risk of opioid overdose in patients with Type 2 diabetes and opioid use disorder, research shows.